Leffler DA , Lamont JT: Clostridium difficile infection. N Engl J Med 372, 1539–1548 (2015)

Leffler DA , LamontJT: Clostridium difficile infection. N Engl J Med372, 1539–1548 (2015))| false
• Search Google Scholar
• Export Citation

Martin JS , Monaghan TM, Wilcox MH: Clostridium difficile infection: epidemiology, diagnosis and understanding transmission. Nat Rev Gastroenterol Hepatol 13, 206–216 (2016)

Martin JS , MonaghanTM, WilcoxMH: Clostridium difficile infection: epidemiology, diagnosis and understanding transmission. Nat Rev Gastroenterol Hepatol13, 206–216 (2016))| false
• Search Google Scholar
• Export Citation

Bassetti M , Villa G, Pecori D, Arzese A, Wilcox M: Epidemiology, diagnosis and treatment of Clostridium difficile infection. Expert Rev Anti Infect Ther 10, 1405–1423 (2012)

Bassetti M , VillaG, PecoriD, ArzeseA, WilcoxM: Epidemiology, diagnosis and treatment of Clostridium difficile infection. Expert Rev Anti Infect Ther10, 1405–1423 (2012))| false
• Search Google Scholar
• Export Citation

Bauer MP , Notermans DW, van Benthem BH, Brazier JS, Wilcox MH, Rupnik M, Monnet DL, van Dissel JT, Kuijper EJ, Group ES: Clostridium difficile infection in Europe: a hospital-based survey. Lancet 377, 63–73 (2011)

Bauer MP , NotermansDW, van BenthemBH, BrazierJS, WilcoxMH, RupnikM, MonnetDL, van DisselJT, KuijperEJ, GroupES: Clostridium difficile infection in Europe: a hospital-based survey. Lancet377, 63–73 (2011))| false
• Search Google Scholar
• Export Citation

Wiegand PN , Nathwani D, Wilcox MH, Stephens J, Shelbaya A, Haider S: Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection. J Hosp Infect 81, 1–14 (2012)

Wiegand PN , NathwaniD, WilcoxMH, StephensJ, ShelbayaA, HaiderS: Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection. J Hosp Infect81, 1–14 (2012))| false
• Search Google Scholar
• Export Citation

Zhang S , Palazuelos-Munoz S, Balsells EM, Nair H, Chit A, Kyaw MH: Cost of hospital management of Clostridium difficile infection in United States—a meta-analysis and modelling study. BMC Infect Dis 16, 447 (2016)

Zhang S , Palazuelos-MunozS, BalsellsEM, NairH, ChitA, KyawMH: Cost of hospital management of Clostridium difficile infection in United States—a meta-analysis and modelling study. BMC Infect Dis16, 447 (2016))| false
• Search Google Scholar
• Export Citation

CDC: United States Centers for Disease Control and Prevention. Nearly half a million Americans suffered from Clostridium difficile infections in a single year. Page last reviewed March 22, 2017. Available at: https://www.cdc. gov/media/releases/2015/p0225-clostridium-difficile.html. [Last accessed: August 20, 2017]

CDC: United States Centers for Disease Control and Prevention. Nearly half a million Americans suffered from Clostridium difficile infections in a single year. Page last reviewed March 22, 2017. Available at: https://www.cdc. gov/media/releases/2015/p0225-clostridium-difficile.html. [Last accessed: August 20, 2017])| false
• Search Google Scholar
• Export Citation

Lessa FC , Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, Farley MM, Holzbauer SM, Meek JI, Phipps EC, Wilson LE, Winston LG, Cohen JA, Limbago BM, Fridkin SK, Gerding DN, McDonald LC: Burden of Clostridium difficile infection in the United States. N Engl J Med 372, 825–834 (2015)

Lessa FC , MuY, BambergWM, BeldavsZG, DumyatiGK, DunnJR, FarleyMM, HolzbauerSM, MeekJI, PhippsEC, WilsonLE, WinstonLG, CohenJA, LimbagoBM, FridkinSK, GerdingDN, McDonaldLC: Burden of Clostridium difficile infection in the United States. N Engl J Med372, 825–834 (2015))| false
• Search Google Scholar
• Export Citation

Cartman ST , Heap JT, Kuehne SA, Cockayne A, and Minton NP: The emergence of ‘hypervirulence’ in Clostridium difficile. Int J Med Microbiol 300, 387–395 (2010)

Cartman ST , HeapJT, KuehneSA, CockayneA, and MintonNP: The emergence of ‘hypervirulence’ in Clostridium difficile. Int J Med Microbiol300, 387–395 (2010))| false
• Search Google Scholar
• Export Citation

Jones AM , Kuijper EJ, Wilcox MH: Clostridium difficile: a European perspective. J Infect 66, 115–128 (2013)

Jones AM , KuijperEJ, WilcoxMH: Clostridium difficile: a European perspective. J Infect66, 115–128 (2013))| false
• Search Google Scholar
• Export Citation

Fang FC , Polage CR, Wilcox MH: Point-counterpoint: what is the optimal approach for detection of Clostridium difficile infection? J Clin Microbiol 55, 670–680 (2017)

Fang FC , PolageCR, WilcoxMH: Point-counterpoint: what is the optimal approach for detection of Clostridium difficile infection? J Clin Microbiol55, 670–680 (2017))| false
• Search Google Scholar
• Export Citation

Burnham CA , Carroll KC: Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories. Clin Microbiol Rev 26, 604–630 (2013)

Burnham CA , CarrollKC: Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories. Clin Microbiol Rev26, 604–630 (2013))| false
• Search Google Scholar
• Export Citation

van Dorp SM , Notermans DW, Alblas J, Gastmeier P, Mentula S, Nagy E, Spigaglia P, Ivanova K, Fitzpatrick F, Barbut F, Morris T, Wilcox MH, Kinross P, Suetens C, Kuijper EJ, European Clostridium difficile Infection Surveillance Network project on behalf of all participants: Survey of diagnostic and typing capacity for Clostridium difficile infection in Europe, 2011 and 2014. Euro Surveill 21 (2016)

van Dorp SM , NotermansDW, AlblasJ, GastmeierP, MentulaS, NagyE, SpigagliaP, IvanovaK, FitzpatrickF, BarbutF, MorrisT, WilcoxMH, KinrossP, SuetensC, KuijperEJ, European Clostridium difficile Infection Surveillance Network project on behalf of all participants: Survey of diagnostic and typing capacity for Clostridium difficile infection in Europe, 2011 and 2014. Euro Surveill 21 (2016))| false
• Search Google Scholar
• Export Citation

Polage CR , Gyorke CE, Kennedy MA, Leslie JL, Chin DL, Wang S, Nguyen HH, Huang B, Tang YW, Lee LW, Kim K, Taylor S, Romano PS, Panacek EA, Goodell PB, Solnick JV, Cohen SH: Overdiagnosis of Clostridium difficile infection in the molecular test era. JAMA Intern Med 175, 1792–1801 (2015)

Polage CR , GyorkeCE, KennedyMA, LeslieJL, ChinDL, WangS, NguyenHH, HuangB, TangYW, LeeLW, KimK, TaylorS, RomanoPS, PanacekEA, GoodellPB, SolnickJV, CohenSH: Overdiagnosis of Clostridium difficile infection in the molecular test era. JAMA Intern Med175, 1792–1801 (2015))| false
• Search Google Scholar
• Export Citation

Butler MOA , Drekonja D, Shaukat A, Schwehr N, Shippee N, Wilt TJ: Early Diagnosis, Prevention, and Treatment of Clostridium difficile: Update. Comparative Effectiveness Review No. 172. (Prepared by the Minnesota Evidencebased Practice Center under Contract No. 290-2012-00016- I.) AHRQ Publication No. 16 EHC012-EF.Agency for Healthcare Research and Quality, Rockville, MD, March 2016.

Butler MOA , DrekonjaD, ShaukatA, SchwehrN, ShippeeN, WiltTJ: Early Diagnosis, Prevention, and Treatment of Clostridium difficile: Update. Comparative Effectiveness Review No. 172. (Prepared by the Minnesota Evidencebased Practice Center under Contract No. 290-2012-00016- I.) AHRQ Publication No. 16 EHC012-EF.Agency for Healthcare Research and Quality, Rockville, MD, March 2016.)| false
• Search Google Scholar
• Export Citation

Crobach MJ , Planche T, Eckert C, Barbut F, Terveer EM, Dekkers OM, Wilcox MH, Kuijper EJ: European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection. Clin Microbiol Infect 22 Suppl 4, S63–81 (2016)

Crobach MJ , PlancheT, EckertC, BarbutF, TerveerEM, DekkersOM, WilcoxMH, KuijperEJ: European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection. Clin Microbiol Infect22 Suppl 4, S63–81 (2016))| false
• Search Google Scholar
• Export Citation

Bomers MK , Menke FP, Savage RS, Vandenbroucke-Grauls CM, van Agtmael MA, Covington JA, Smulders YM: Rapid, accurate, and on-site detection of C. difficile in stool samples. Am J Gastroenterol 110, 588–594 (2015)

Bomers MK , MenkeFP, SavageRS, Vandenbroucke-GraulsCM, van AgtmaelMA, CovingtonJA, SmuldersYM: Rapid, accurate, and on-site detection of C. difficile in stool samples. Am J Gastroenterol110, 588–594 (2015))| false
• Search Google Scholar
• Export Citation

Kundrapu S , Jury LA, Sitzlar B, Sunkesula VC, Sethi AK, Donskey CJ: Easily modified factors contribute to delays in diagnosis of Clostridium difficile infection: a cohort study and intervention. J Clin Microbiol 51, 2365–2370 (2013)

Kundrapu S , JuryLA, SitzlarB, SunkesulaVC, SethiAK, DonskeyCJ: Easily modified factors contribute to delays in diagnosis of Clostridium difficile infection: a cohort study and intervention. J Clin Microbiol51, 2365–2370 (2013))| false
• Search Google Scholar
• Export Citation

Scheurer D : Diagnostic and treatment delays in recurrent Clostridium difficile-associated disease. J Hosp Med 3, 156–159 (2008)

Scheurer D : Diagnostic and treatment delays in recurrent Clostridium difficile-associated disease. J Hosp Med3, 156–159 (2008))| false
• Search Google Scholar
• Export Citation

FDA: United States Food and Drug Administration – Nucleic Acid Based Tests: List of Microbial Tests. This is a list of nucleic acid-based tests that have been cleared or approved by the Center for Devices and Radiological Health. These tests analyze variations in the sequence, structure, or expression of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in order to diagnose disease or medical conditions, infection with an identifiable pathogen, and determine genetic carrier status.

FDA: United States Food and Drug Administration – Nucleic Acid Based Tests: List of Microbial Tests. This is a list of nucleic acid-based tests that have been cleared or approved by the Center for Devices and Radiological Health. These tests analyze variations in the sequence, structure, or expression of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in order to diagnose disease or medical conditions, infection with an identifiable pathogen, and determine genetic carrier status.)| false
• Search Google Scholar
• Export Citation

Peterson LR , Young SA, Davis TE Jr, Wang ZX, Duncan J, Noutsios C, Liesenfeld O, Osiecki JC, Lewinski MA: Evaluation of the cobas(R) Cdiff test for the detection of toxigenic Clostridium difficile in stool samples. J Clin Microbiol 2017.

Peterson LR , YoungSA, DavisTE Jr, WangZX, DuncanJ, NoutsiosC, LiesenfeldO, OsieckiJC, LewinskiMA: Evaluation of the cobas(R) Cdiff test for the detection of toxigenic Clostridium difficile in stool samples. J Clin Microbiol2017.)| false
• Search Google Scholar
• Export Citation

Buchan BW , Ledeboer NA: Emerging technologies for the clinical microbiology laboratory. Clin Microbiol Rev 27, 783–822 (2014)

Buchan BW , LedeboerNA: Emerging technologies for the clinical microbiology laboratory. Clin Microbiol Rev27, 783–822 (2014))| false
• Search Google Scholar
• Export Citation

Robinson A , Marcon M, Mortensen JE, McCarter YS, LaRocco M, Peterson LR, Thomson RB Jr: Controversies affecting the future practice of clinical microbiology. J Clin Microbiol 37, 883–889 (1999)

Robinson A , MarconM, MortensenJE, McCarterYS, LaRoccoM, PetersonLR, ThomsonRB Jr: Controversies affecting the future practice of clinical microbiology. J Clin Microbiol37, 883–889 (1999))| false
• Search Google Scholar
• Export Citation

Halligan E , Edgeworth J, Bisnauthsing K, Bible J, Cliff P, Aarons E, Klein J, Patel A, Goldenberg S: Multiplex molecular testing for management of infectious gastroenteritis in a hospital setting: a comparative diagnostic and clinical utility study. Clin Microbiol Infect 20, O460–467 (2014)

Halligan E , EdgeworthJ, BisnauthsingK, BibleJ, CliffP, AaronsE, KleinJ, PatelA, GoldenbergS: Multiplex molecular testing for management of infectious gastroenteritis in a hospital setting: a comparative diagnostic and clinical utility study. Clin Microbiol Infect20, O460–467 (2014))| false
• Search Google Scholar
• Export Citation

Melchers WJG , Kuijpers J, Sickler JJ, Rahamat-Langendoen J: Lab-in-a-tube: real-time molecular point-of-care diagnostics for influenza A and B using the cobas(R) Liat(R) system. J Med Virol 89, 1382–1386 (2017)

Melchers WJG , KuijpersJ, SicklerJJ, Rahamat-LangendoenJ: Lab-in-a-tube: real-time molecular point-of-care diagnostics for influenza A and B using the cobas(R) Liat(R) system. J Med Virol89, 1382–1386 (2017))| false
• Search Google Scholar
• Export Citation

cobas® Cdiff Nucleic acid test for use on the cobas® Liat® System. Manufacturers Instructions for Use. For In Vitro Diagnostic Use. Roche Molecular Systems, Inc., Marlborough, MA, USA (2017).

cobas® Cdiff Nucleic acid test for use on the cobas® Liat® System. Manufacturers Instructions for Use. For In Vitro Diagnostic Use. Roche Molecular Systems, Inc., Marlborough, MA, USA (2017).)| false
• Search Google Scholar
• Export Citation

Moure R , Canizares A, Muino M, Lobato M, Fernandez A, Rodriguez M, Gude MJ, Tomas M, Bou G: Use of the cobas 4800 system for the rapid detection of toxigenic Clostridium difficile and methicillin-resistant Staphylococcus aureus. J Microbiol Methods 120, 50–52 (2016)

Moure R , CanizaresA, MuinoM, LobatoM, FernandezA, RodriguezM, GudeMJ, TomasM, BouG: Use of the cobas 4800 system for the rapid detection of toxigenic Clostridium difficile and methicillin-resistant Staphylococcus aureus. J Microbiol Methods120, 50–52 (2016))| false
• Search Google Scholar
• Export Citation

Kociolek LK , Gerding DN: Clinical utility of laboratory detection of Clostridium difficile strain BI/NAP1/027. J Clin Microbiol 54, 19–24 (2016)

Kociolek LK , GerdingDN: Clinical utility of laboratory detection of Clostridium difficile strain BI/NAP1/027. J Clin Microbiol54, 19–24 (2016))| false
• Search Google Scholar
• Export Citation

Rupnik M : Heterogeneity of large clostridial toxins: importance of Clostridium difficile toxinotypes. FEMS Microbiol Rev 32, 541–555 (2008)

Rupnik M : Heterogeneity of large clostridial toxins: importance of Clostridium difficile toxinotypes. FEMS Microbiol Rev32, 541–555 (2008))| false
• Search Google Scholar
• Export Citation

O’Connor JR , Johnson S, Gerding DN: Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology 136, 1913–1924 (2009)

O’Connor JR , JohnsonS, GerdingDN: Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology136, 1913–1924 (2009))| false
• Search Google Scholar
• Export Citation

Gerding DN , Johnson S, Rupnik M, Aktories K: Clostridium difficile binary toxin CDT: mechanism, epidemiology, and potential clinical importance. Gut Microbes 5, 15–27 (2014)

Gerding DN , JohnsonS, RupnikM, AktoriesK: Clostridium difficile binary toxin CDT: mechanism, epidemiology, and potential clinical importance. Gut Microbes5, 15–27 (2014))| false
• Search Google Scholar
• Export Citation

Eckert C , Emirian A, Le Monnier A, Cathala L, De Montclos H, Goret J, Berger P, Petit A, De Chevigny A, Jean-Pierre H, Nebbad B, Camiade S, Meckenstock R, Lalande V, Marchandin H, Barbut F: Prevalence and pathogenicity of binary toxin-positive Clostridium difficile strains that do not produce toxins A and B. New Microbes New Infect 3, 12–17 (2015)

Eckert C , EmirianA, Le MonnierA, CathalaL, De MontclosH, GoretJ, BergerP, PetitA, De ChevignyA, Jean-PierreH, NebbadB, CamiadeS, MeckenstockR, LalandeV, MarchandinH, BarbutF: Prevalence and pathogenicity of binary toxin-positive Clostridium difficile strains that do not produce toxins A and B. New Microbes New Infect3, 12–17 (2015))| false
• Search Google Scholar
• Export Citation

Eyre DW , Cule ML, Wilson DJ, Griffiths D, Vaughan A, O’Connor L, Ip, CLC, Golubchik T, Batty EM, Finney JM, Wyllie DH, Didelot X, Piazza P, Bowden R, Dingle KE, Harding RM, Crook DW, Wilcox MH, Peto TEA, Walker AS: Diverse sources of C. difficile infection identified on whole-genome sequencing. N Engl J Med 369, 1195–1205 (2013)

Eyre DW , CuleML, WilsonDJ, GriffithsD, VaughanA, O’ConnorL, Ip,CLC, GolubchikT, BattyEM, FinneyJM, WyllieDH, DidelotX, PiazzaP, BowdenR, DingleKE, HardingRM, CrookDW, WilcoxMH, PetoTEA, WalkerAS: Diverse sources of C. difficile infection identified on whole-genome sequencing. N Engl J Med369, 1195–1205 (2013))| false
• Search Google Scholar
• Export Citation

Senchyna F , Gaur RL, Gombar S, Truong CY, Schroeder LF, Banaei N: Clostridium difficile PCR cycle threshold predicts free toxin. J Clin Microbiol 2017.

Senchyna F , GaurRL, GombarS, TruongCY, SchroederLF, BanaeiN: Clostridium difficile PCR cycle threshold predicts free toxin. J Clin Microbiol2017.)| false
• Search Google Scholar
• Export Citation

Longtin Y , Gilca R, Loo VG: Effect of detecting and isolating asymptomatic Clostridium difficile carriers-reply. JAMA Intern Med 176, 1573 (2016)

Longtin Y , GilcaR, LooVG: Effect of detecting and isolating asymptomatic Clostridium difficile carriers-reply. JAMA Intern Med176, 1573 (2016))| false
• Search Google Scholar
• Export Citation

Tenover FC , Baron EJ, Peterson LR, Persing DH: Laboratory diagnosis of Clostridium difficile infection can molecular amplification methods move us out of uncertainty? J Mol Diagn 13, 573–582 (2011)

Tenover FC , BaronEJ, PetersonLR, PersingDH: Laboratory diagnosis of Clostridium difficile infection can molecular amplification methods move us out of uncertainty? J Mol Diagn13, 573–582 (2011))| false
• Search Google Scholar
• Export Citation

Goldenberg SD , Bisnauthsing KN, Patel A, Postulka A, Wyncoll D, Schiff R, French GL: Point-of-care testing for Clostridium difficile infection: a real-world feasibility study of a rapid molecular test in two hospital settings. Infect Dis Ther 3, 295–306 (2014)

Goldenberg SD , BisnauthsingKN, PatelA, PostulkaA, WyncollD, SchiffR, FrenchGL: Point-of-care testing for Clostridium difficile infection: a real-world feasibility study of a rapid molecular test in two hospital settings. Infect Dis Ther3, 295–306 (2014))| false
• Search Google Scholar
• Export Citation

Hui-Hsing W : Assessing Strategies to Improve the Market for Rapid Diagnostics for Bacterial Diseases Session III: Addressing the post-market economic challenges to diagnostics development (Presentation). April 18, 2017. Washington, DC.

Hui-Hsing W : Assessing Strategies to Improve the Market for Rapid Diagnostics for Bacterial Diseases Session III: Addressing the post-market economic challenges to diagnostics development (Presentation). April 18, 2017. Washington, DC.)| false
• Search Google Scholar
• Export Citation

Cohen-Bacrie S , Ninove L, Nougairede A, Charrel R, Richet H, Minodier P, Badiaga S, Noel G, La Scola B, de Lamballerie X, Drancourt M, Raoult D: Revolutionizing clinical microbiology laboratory organization in hospitals with in situ point-of-care. PLoS One 6, e22403 (2011)

Cohen-Bacrie S , NinoveL, NougairedeA, CharrelR, RichetH, MinodierP, BadiagaS, NoelG, La ScolaB, de LamballerieX, DrancourtM, RaoultD: Revolutionizing clinical microbiology laboratory organization in hospitals with in situ point-of-care. PLoS One6, e22403 (2011))| false
• Search Google Scholar
• Export Citation

Patel PA , Schora DM, Singh K, Liesenfeld O, Peterson LR: Validation of active surveillance testing for Clostridium difficile colonization using the cobas® Cdiff test (in submission).

Patel PA , SchoraDM, SinghK, LiesenfeldO, PetersonLR: Validation of active surveillance testing for Clostridium difficile colonization using the cobas® Cdiff test (in submission).)| false
• Search Google Scholar
• Export Citation

Mason J : Point-of-care testing for influenza. CADTH Issues in Emerging Health Technologies. Canadian Agency for Drugs and Technologies in Health, Ottawa (ON), 2016 Nov, 149.

Moore C : Point-of-care tests for infection control: should rapid testing be in the laboratory or at the front line? J Hosp Infect 85, 1–7 (2013)

Moore C : Point-of-care tests for infection control: should rapid testing be in the laboratory or at the front line? J Hosp Infect85, 1–7 (2013))| false
• Search Google Scholar
• Export Citation